Are South Indians genetically more prone to heart disease? The answer, according to new research, might surprise you—and even challenge long-held medical beliefs.
A recent study from the Institute for Stem Cell Science and Regenerative Medicine (inStem) in Bengaluru has unveiled something extraordinary. Published in the Journal of the American Heart Association, this research discovered a distinct genetic signature for Hypertrophic Cardiomyopathy (HCM) among people of South Indian heritage. And this revelation could rewrite how heart disease is understood—and treated—in India.
HCM, a severe heart condition marked by an abnormal thickening of the heart muscle, often leads to heart failure or even sudden cardiac arrest. According to healthcare reports, the condition remains one of the leading hidden causes of unexplained cardiac deaths worldwide. But here’s where it gets especially interesting: South Indian patients appear to carry a genetic pattern that’s remarkably different from Western populations.
Key discoveries from the study
The research analyzed detailed genetic data from 335 South Indian patients diagnosed with primary HCM. The results paint a strikingly different picture compared to European and North American data.
- Fewer Conventional Mutations: The study found that South Indian patients had far fewer mutations in the two genes that are most often linked to HCM globally — MYBPC3 and MYH7.
- Greater Genetic Diversity: Instead, researchers observed increased variation in other genes, including one called Mi Hb, which was previously overlooked or thought to play a minor role.
Dr. Perundurai S. Dhandapany, Associate Professor at BRIC-inStem and the study’s lead author, explained the broader potential of this work: “Our discovery allows us to explore other genetic disorders where Indians may show unique patterns. This could help design better screening programs to predict and prevent sudden cardiac deaths more effectively.”
Redefining global assumptions
This unexpected genetic profile challenges decades of Western-centric thinking in cardiology. For years, global research assumed that what applied genetically to European or American patients would also apply worldwide. But this study flips that idea on its head, showing that India’s diverse genetic landscape cannot be explained by Western data alone. It raises a bold question: Is global heart disease research overlooking key regional genetic realities?
The implications are profound. If common diagnostic tests or treatments are built around foreign genetic datasets, they may fail to identify risks among Indian patients. This highlights why region-specific genetic studies aren’t just beneficial—they’re necessary for truly equitable healthcare.
The promise of precision medicine
By mapping these unique genetic mutations, doctors can now refine diagnostic accuracy and assess risks earlier. This means better-targeted interventions, smarter treatment plans, and potentially life-saving early warnings for patients at risk of sudden cardiac arrest.
For young adults in particular—who often live active, undiagnosed lives—this kind of genetic screening could make the difference between prevention and tragedy. The research moves India closer to a future where cardiac care is personalized, predictive, and driven by the country’s own genetic data, not borrowed global averages.
Dr. Dhandapany emphasized the transformative nature of the findings: “Understanding these regional genetic variations can help create diagnostic tools tailored for South Indians. These tools will enable timely detection and treatment, improving patient outcomes dramatically.”
A turning point for Indian cardiac care
In short, this study does more than reveal a scientific insight—it sparks a paradigm shift. It invites the global medical community to recognize that genetics, geography, and ancestry matter far more than previously assumed. Personalized medicine for India’s diverse population isn’t just possible; it’s becoming a reality.
But here’s the part most people overlook: if South Indians have distinct heart disease genetics, what about other Indian subgroups and regions? Should each community be studied individually to uncover hidden health risks?
What do you think—does this signify the beginning of a new era of Indian-focused genetic research, or will it face resistance from traditional, Western-centric medical models? Share your thoughts in the comments.
